Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 481 (CSE: $PRMO.C) (TSXV: $ENW.V) (CSE: $IPOT.C) (TSX: $FAF.TO) (OTCQX: $FFLWF)
Today's
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/101420-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/10141PRMO-ENW-IPOT-FAF-FFLWF-CSUI.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on
Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis
cultivation and distribution company in Switzerland, for recreational tobacco
products and medical CBD oils. The Company's facilities for producing cannabis
are based in Dietikon, Switzerland, and contain the art surveillance equipment
to enable an around the clock webcast. Cannabis Suisse grows high quality,
organic cannabis with sustainable, all-natural principles. The Company's
products are laboratory tested to ensure the end users have access to a standardized,
safe and consistent product. Cannabis Suisse proprietary trademarked
MoldStandard is a quantitative microbiology method for analyzing yeast and mold
counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked
CannaMec is a method for quantifying and removing residual solvents during
packaging and storage of CBD products. Cannabis Suisse Corp. currently sells
via a distribution network of Swiss retailers and online shops, under the
retail brand Alpine Cannabis.
In
today’s podcast we look at a few public company announcements.
PRIMO
NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) announced entering into a non-binding letter
of intent with MedCanBiotechnologies
Inc. who will act as a consultant to conduct a chemo typing (Chemical
Analysis) and a genotyping (Genetic Analysis) study of up to 5 strains of
Psilocybin mushrooms (commonly known as Magic Mushrooms).
Health Canada (HC) has recently
shifted towards psychedelic-assisted psychotherapies in safe, controlled
environments as acceptable treatment options.
Pursuant to Section 56 exemption
from the Canadian Drugs and Substances Act to treat anxiety associated
diagnoses,MEDCAN BIOTECH will apply to Health Canada to receive approval under
the Controlled Drug and Substances Act to allow MEDCAN BIOTECH to conduct
research in order to effectively standardize the extraction of psilocybin from
mushrooms.
The Health Canada permit by MEDCAN
BIOTECH will allow it to develop and license intellectual property (IP)
exclusively for further product development by PRIMO via chemo-typing and
geno-typing of 5 different mushrooms to understand their properties.
MEDCAN BIOTECHwill proceed to patent
methods of analysis and results on behalf of PRIMO, whereby data generated will
be used in the production of nutraceutical products.
All IP and products developed as a
result of the analysis will become the property of PRIMOfor their exclusive
use.
Psychedelic research focused on
psychedelic medicine and psychedelic drugs have demonstrated that these
substances have potential for treating ailments including anxiety, addiction,
depression, substance dependency, attention deficit hyperactivity disorder and
even post-traumatic stress disorder.The data produced can be used to generate
premium natural health mushroom nutraceutical products. Genotyping can be used
for the identification and labeling of different varieties of psilocybin
mushrooms.
EnWave
Corporation (TSX-V:ENW) announced today that it has signed a
Technology Evaluation and License Option Agreement with an American industrial
hemp producer to evaluate the potential commercial use of the Company’s
proprietary Radiant Energy Vacuum (“REV™”) dehydration technology. During the
term of the TELOA, the Hemp Producer will pay a monthly evaluation fee and have
the exclusive option to license REV™ technology for
use in the State of Illinois to
dehydrate hemp products for cannabidiol (“CBD”) extraction.
If REV™ demonstrates its proven
ability to produce dried hemp with zero degradation of CBD content, the Hemp
Producer will be able to leverage EnWave’s patented dehydration platform to
improve processing efficiencies and lower their cost of CBD production. If the
evaluation is deemed successful by the Hemp Producer, EnWave will aim to sign a
royalty-bearing commercial license agreement and an Equipment Purchase
Agreement with the Hemp Producer committing to the purchase of REV™ machinery.
EnWave holds a robust intellectual
property portfolio spanning numerous international markets and has licensed
REV™ technology to more than forty companies operating in eighteen countries
worldwide.
Isracann
Biosciences Inc. (CSE: IPOT) (OTC: ISCNF), an Israel-based company focused
on becoming a premier low cost, high quality cannabis producer, announced that the government of Israel has
officially enacted the legislation for the export of medical cannabis, clearing
the way for sales abroad that the government expects could generate more than 1
billion shekels ($273 million) in annual revenue.
Economy Minister Eli Cohen gave
final approval for the exports more than a year after the cabinet initially
supported the legislation. Within Israel, medical use of cannabis is permitted
with recreational use largely decriminalised. The ministry reports about 70,000
Israelis currently use medical cannabis consuming an estimated 25 tonnes per
year. If this growth trend continues, Israel could see a market of over 200,000
medical patients consuming 85 tonnes per year within the next two years.
As reported by Reuters, Hagit
Weinstock, co-founder of the Weinstock-Zehavi & Co. law firm and a pioneer
of cannabis regulation in Israel stated, “There are many investments that we
are expected to see happening now, because investors were waiting for this
approval.”
According to recent reports, the
Israeli Ministry of Health has launched a new pilot program whereby medical
cannabis producers will be approved to export medical cannabis, subject to
concurrent product availability to Israeli patients at a fixed discount price
of NIS14 per gram (CAD$5.50 per gram) for patients over 21 years old, and NIS10
(CAD$4.00 per gram) for those patients under 21 years old.
Previous
reports have
outlined how Israel has struggled with cannabis product shortages, as well as
complaints about price and quality, which led to the country becoming one of
the world’s largest importers of medical cannabis. The pilot program is planned
for an initial three-month period during which the specific medical cannabis
products to be provided in Israel and made available for export are at the
individual producer’s discretion.
Company COO Matt Chatterton notes,
“Todays news is a win-win for both the medical patients in Israel and the
domestic producers. Export licensing will be a huge economic driver for the
licensed producers and an incentive for investment that should spur rapid
growth across the industry. The government’s plan to ensure subsidies for the
domestic market will see supply finally catch up to demand along with stabilization
of the supply chain through improved product processing and quality assurance
that is required for entry into export markets. Its been an extensive process
to get to where we are today, but with todays announcement we find ourselves in
great shape as we continue to build our company and shareholder value in
Israel.”
Fire
& Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) and its wholly-owned subsidiary
Fire & Flower Inc. today announced the launch of a private-label
brand collaboration with Decibel Cannabis Company Inc's, premium cannabis brand
"Qwest".
The brand collaboration is
anticipated to launch on October 15, 2020 in the province of Saskatchewan.
Decibel will manufacture, package and ship the private-label products to Open
Fields Distribution, Fire & Flower's wholly-owned Saskatchewan distribution
business.
The initial product launch will
include a pre-rolled format and the Company may look to expand the offering to
other products in the future. Spark Perks™ members will receive special
member-only pricing and exclusive early access when the products are available
in retail stores this week.
"We are pleased to announce
this curated product offering to our customers. Qwest products are in high
demand in the premium cannabis product category and our collaboration on these
private label products will deliver high quality and value to the Fire &
Flower customer," shared Nadia Vattovaz, Executive Vice President,
Operations and Chief Financial Officer of Fire & Flower. "Our ability
to work directly with licensed producers, though our wholesale business, Open
Fields Distribution in the province of Saskatchewan demonstrates how this
province is leading the Canadian cannabis industry and we believe other
provinces should look to how this model can best serve consumers and help
eradicate the illegal and unregulated market."
"Decibel is excited to partner
with Canada's leading retailer to launch a series of premium pre-rolls,
exclusively for Fire & Flower customers," said Adam Coates, Chief
Growth Officer of Decibel. "This collaboration allows Qwest the
opportunity to provide craft cannabis to a group of new customers while also
offering value to Fire & Flower Spark Perks members."
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors
can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on
Investorideas.com
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for iPhone
and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Good website! I truly love how it is easy on my eyes it is. I am wondering how I might be notified whenever a new post has been made. I have subscribed to your RSS which may do the trick? Have a great day!
ReplyDeleteIndex Funds